Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing Fulcrum Therapeutics' Phase 1b PIONEER Trial of Pociredir and Beam Therapeutics' Phase 1/2 clinical trial for BEAM-101 in Sickle Cell Disease.

Ticker(s): FULC, BEAM

Who's the expert?

Hematologist

Interview Goal

This conversation will focus on the treatment landscape and potential use of Pociredir and BEAM-101 for patients with sickle cell disease.

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here To Join
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Call Date: Oct 27, 2025
Call Time: 03:00 PM EDT

Tentative Call Date/Time

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here To Join
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.